ScholarIQanswers from OpenAlex
Ludwig Boltzmann Institute Applied Diagnostics
InstitutionResearch output, impact & collaborations
Ludwig Boltzmann Institute Applied Diagnostics is a institution indexed in ScholarIQ from OpenAlex.
What is known about Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQrecord summary
Ludwig Boltzmann Institute Applied Diagnostics is a research organisation in Vienna, AT. OpenAlex records 1,081 works and 96,619 citations for it. 188 researchers list it as their most recent affiliation.
How many works does Ludwig Boltzmann Institute Applied Diagnostics have?
ScholarIQindexed works
Ludwig Boltzmann Institute Applied Diagnostics has 1,081 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ludwig Boltzmann Institute Applied Diagnostics have?
ScholarIQcitation count
Ludwig Boltzmann Institute Applied Diagnostics has 96,619 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQresearcher count
Ludwig Boltzmann Institute Applied Diagnostics has 188 researchers in the ScholarIQ index.
What is the average h-index at Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQavg h-index
Ludwig Boltzmann Institute Applied Diagnostics has an average h-index of 131 in OpenAlex.
What is the ROR of Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQror
The ROR for Ludwig Boltzmann Institute Applied Diagnostics is on the source record.
What is the OpenAlex record for Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQopenalex
The OpenAlex for Ludwig Boltzmann Institute Applied Diagnostics is on the source record.
Who are the most-cited researchers behind Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQtop researchers by citations
What are the most-cited papers on Ludwig Boltzmann Institute Applied Diagnostics?
ScholarIQmost cited works
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian, Ana Barac, Anne Blaes, Daniela Cardinale, Joseph R. Carver, Susan Dent, Bonnie Ky, Alexander R. Lyon, Teresa López‐Fernández, Michael G. Fradley, Sarju Ganatra, Giuseppe Curigliano, Joshua D. Mitchell, Giorgio Minotti, Ninian N. Lang, Jennifer E. Liu, Tomas G. Neilan, Anju Nohria, Rupal O’Quinn, Iskra Pusic, Charles Porter, Kerry L. Reynolds, Kathryn J. Ruddy, Paaladinesh Thavendiranathan, Peter Valent
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer, Günther Bayer, Michael Bergmann, Sandra Eder, Ruth Eichner, Martin Erl, Harald Esterbauer, Ruth Exner, Verena Felsleitner-Hauer, Maurizio Forte, Alexander Gaiger, Klaus Geißler, Hildegard Greinix, Wolfgang Gstöttner, Marcus Hacker, Bernd Hartmann, Alexander W. Hauswirth, Tim Heinemann, Daniel Heintel, Mir Alireza Hoda, Georg Hopfinger, Ulrich Jaeger, Lukas Kazianka, Lukas Kenner, Barbara Kiesewetter, Nikolaus Krall, G. Krajnik, Stefan Kubicek, Trang Le, Simone Lubowitzki, Marius E. Mayerhoefer, Elisabeth Menschel, Olaf Merkel, Katsuhiro Miura, Leonhard Müllauer, Peter Neumeister, Thomas Noesslinger, Katharina Ocko, Leopold Öhler, Michael Panny, Alexander Pichler, Edit Porpaczy, Gerald W. Prager, Markus Raderer, Robin Ristl, Reinhard Ruckser, Julius Salamon, Ana‐Iris Schiefer, Ann-Sofie Schmolke, Ilse Schwarzinger, Edgar Selzer, Christian Sillaber, Cathrin Skrabs, Wolfgang R. Sperr, Ismet Srndic, Renate Thalhammer, Peter Valent, Emiel van der Kouwe, Katrina Vanura, Stefan Vogt, Cora Waldstein, Dominik Wolf, Christoph Zielinski, Niklas Zojer, Ingrid Simonitsch‐Klupp, Giulio Superti‐Furga, Berend Snijder, Philipp B. Staber
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study
Berend Snijder, Gregory I. Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin, Lukas Kazianka, Johannes W. Bigenzahn, Gregor Hoermann, Nicole Prutsch, Olaf Merkel, Anna Ringler, Monika Sabler, Georg Jeryczynski, Marius E. Mayerhoefer, Ingrid Simonitsch‐Klupp, Katharina Ocko, Franz X. Felberbauer, Leonhard Müllauer, Gerald W. Prager, Belgin Korkmaz, Lukas Kenner, Wolfgang R. Sperr, Róbert Královics, Heinz Gisslinger, Peter Valent, Stefan Kubicek, Ulrich Jäger, Philipp B. Staber, Giulio Superti‐Furga
Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients
Abdolreza Rezaie-Majd, Gerald W. Prager, Robert A. Bucek, G. Schernthaner, Thomas Maca, Hans G. Kress, Peter Valent, Bernd R. Binder, Erich Minar, Mehrdad Baghestanian
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R. Sperr, Michael Kundi, Iván Álvarez‐Twöse, Björn van Anrooij, J. N. G. Oude Elberink, Aleksandra Górska, Marek Niedoszytko, Karoline V. Gleixner, Emir Hadzijusufovic, Roberta Zanotti, Patrizia Bonadonna, Massimiliano Bonifacio, Cecelia Perkins, Anja Illerhaus, Chiara Elena, Serena Merante, Khalid Shoumariyeh, Nikolas von Bubnoff, Roberta Parente, Mohamad Jawhar, Anna Belloni Fortina, Francesca Caroppo, Knut Brockow, Alexander Zink, David Fuchs, Alex Kilbertus, Akif Selim Yavuz, Michael Doubek, Hans Hägglund, Jens Panse, Vito Sabato, Agnes Bretterklieber, Dietger Niederwieser, Christine Breynaert, Karin Hartmann, Massimo Triggiani, Bogusław Nedoszytko, Andreas Reiter, Alberto Órfão, Olivier Hermine, Jason Gotlib, Michel Arock, Hanneke C. Kluin‐Nelemans, Peter Valent
How much of the research on Ludwig Boltzmann Institute Applied Diagnostics is open access?
ScholarIQopen access share
100%OPEN ACCESS